These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2959361)

  • 1. In vitro expression of secondary antitumor immunity by in vitro tumor-sensitized T cells: inhibition by tumor-induced suppressor T cells.
    Kaymakcalan Z; Spitalny GL; Bursuker I
    Cancer Immunol Immunother; 1987; 25(2):69-74. PubMed ID: 2959361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of the T cells that mediate and suppress adoptive immunotherapy of established tumors.
    Dye ES; North RJ
    J Leukoc Biol; 1984 Jul; 36(1):27-37. PubMed ID: 6234371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide and abrogation of tumor-induced suppressor T cell activity.
    Hoover SK; Barrett SK; Turk TM; Lee TC; Bear HD
    Cancer Immunol Immunother; 1990; 31(2):121-7. PubMed ID: 2138931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide.
    Inge TH; Hoover SK; Frank JL; Kawabata TT; Bethke KP; Bear HD
    Cancer Immunol Immunother; 1992; 35(2):119-26. PubMed ID: 1534514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells.
    Mills CD; North RJ
    J Exp Med; 1983 May; 157(5):1448-60. PubMed ID: 6189937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of tumor-specific suppressor T cell hybridomas.
    Bear HD
    J Surg Res; 1987 Apr; 42(4):369-76. PubMed ID: 2437390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential resistance to growth of a tumor expressing incompatible minor alloantigens reflects regulatory influences rather than differences in anti-minor-CTL-P frequencies.
    Carayanniotis G; Halloran PF
    Cell Immunol; 1985 Mar; 91(1):100-10. PubMed ID: 2857596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of specific antitumor cytotoxic T-lymphocytes in monoculture can be inhibited by T-suppressors from tumor-bearing mice.
    Lupatov AYu ; Brondz BD
    Cancer Biother; 1994; 9(2):123-9. PubMed ID: 7812361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of specific suppressor cells with heat-treated allogeneic tumor cells.
    Chiu KM; Faanes RB; Choi YS
    Cell Immunol; 1980 Feb; 49(2):283-92. PubMed ID: 6444368
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
    Nagarkatti M; Kaplan AM
    J Immunol; 1985 Aug; 135(2):1510-7. PubMed ID: 3159794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity.
    Awwad M; North RJ
    J Exp Med; 1988 Dec; 168(6):2193-206. PubMed ID: 2974065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the autoantibody response to the P815 mastocytoma.
    Prell RA; Kerkvliet NI
    J Immunol; 1997 Mar; 158(6):2695-703. PubMed ID: 9058803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ongoing hapten-specific delayed-type hypersensitivity prevents generation of cytolytic T lymphocytes to the same hapten.
    Wong HL; Battisto JR
    Cell Immunol; 1985 Aug; 94(1):205-14. PubMed ID: 3160488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
    Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
    Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of cytotoxic T lymphocyte development by a minor stimulating locus-induced suppressor cascade that involves Lyt-1+ suppressor T cells, IA- macrophages, and their factors.
    Chow KP; Battisto JR
    J Immunol; 1988 Feb; 140(4):1005-13. PubMed ID: 2963857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.
    Dye ES
    J Immunol; 1986 Feb; 136(4):1510-5. PubMed ID: 3080526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
    Good MF; Nossal GJ
    J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional alterations in CD11b(+)Gr-1(+) cells in mice injected with allogeneic tumor cells and treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Choi JY; Oughton JA; Kerkvliet NI
    Int Immunopharmacol; 2003 Apr; 3(4):553-70. PubMed ID: 12689660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vivo immunosuppressive action of suppressor cells from alloantigen-cyclosporine-treated mice and the capacity of spleen cells to release interleukins and gamma-interferon.
    Yoshimura N; Matsui S; Hamashima T; Kita M; Oka T
    Transplantation; 1988 Jan; 45(1):157-62. PubMed ID: 2962348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.